157528-56-8

Basic information

• Product Name: (R)-1-Benzyl-3-pyrrolidinecarbonitrile
• Synonyms: (R)-1-Benzyl-3-pyrrolidinecarbonitrile;(R)-1-BENZYL-PYRROLIDINE-3-CARBONITRILE;(R)-1-Benzyl-3-pyrrolidinecarbonitrile;EOS-61264
• CAS NO: 157528-56-8
• Molecular Formula: C₁₂H₁₄N₂
• Molecular Weight: 186.253
• Mol File: 157528-56-8.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 313.3°C at 760 mmHg
• Flash Point: 132.8°C
• Appearance: /
• Density: 1.08g/cm3
• Vapor Pressure: 0.0005mmHg at 25°C
• Refractive Index: 1.5340-1.5380
• Storage Temp.: 0-10°C
• CAS DataBase Reference: (R)-1-Benzyl-3-pyrrolidinecarbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-Benzyl-3-pyrrolidinecarbonitrile(157528-56-8)
• EPA Substance Registry System: (R)-1-Benzyl-3-pyrrolidinecarbonitrile(157528-56-8)

Safety Data

• Hazardous Substances Data: 157528-56-8(Hazardous Substances Data)

Usage

General Description

(R)-1-Benzyl-3-pyrrolidinecarbonitrile is a chemical compound with the molecular formula C16H18N2. It is a chiral compound, meaning it has a non-superimposable mirror image, and specifically exists as the (R) enantiomer. (R)-1-Benzyl-3-pyrrolidinecarbonitrile is commonly used as a building block in organic synthesis, with applications in medicinal chemistry and drug development. It is known for its potential as a precursor in the synthesis of various pharmaceutical compounds, including drugs with anti-inflammatory and anti-cancer properties. Additionally, (R)-1-Benzyl-3-pyrrolidinecarbonitrile is also utilized in research and development as a key intermediate in the creation of new chemical entities for potential therapeutic use.

InChI:InChI=1/C12H14N2/c13-8-12-6-7-14(10-12)9-11-4-2-1-3-5-11/h1-5,12H,6-7,9-10H2/t12-/m0/s1

Upstream product

• 143-33-9 sodium cyanide 
• 118354-71-5 (S)-methanesulfonic acid 1-benzylpyrrolidin-3-yl ester 
• 10442-39-4 tetra-n-butylammonium cyanide 
• 101385-90-4 (S)-N-benzyl-3-hydroxypyrrolidine 
• 908598-98-1 (R)-2-Dibenzylamino-butane-1,4-diol 

Downstream Products

• 229323-07-3 (R)-C-(1-benzyl-pyrrolidin-3-yl)-methylamine 
• 351362-84-0 1-((R)-methyl-1-pyrrolidin-3-yl)-ethylamine 
• 157528-57-9 (R)-3-(1-amino-1-methylethyl)-1-benzylpyrrolidine 
• 922718-09-0 1-cyclopropyl-7-fluoro-9-methyl-8-{3-[1-(methylpiperidin-4-ylamino)cyclopropyl]pyrrolidin-1-yl}-4-oxo-4H-quinolizine-3-carboxylic acid 
• 303111-45-7 2-((R)-1-Benzyl-pyrrolidin-3-yl)-ethylamine 
• 303111-44-6 ((S)-1-Benzyl-pyrrolidin-3-yl)-acetonitrile 
• 303111-43-5 (R)-(+)-1-(phenylmethyl)-3-hydroxymethylpyrrolidine 
• 216311-59-0 methyl (R)-(-)-1-(phenylmethyl)-3-pyrrolidinecarboxylate 
• 115687-29-1 (R)-1-Benzyl-pyrrolidine-3-carboxylic acid amide 
• 1212293-24-7 (R)-1-Benzyl-pyrrolidine-3-carboxylic acid; hydrochloride 

Relevant articles and documents

Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections

The clinical management of prosthetic joint infections and other persistent bacterial infections represents a major unmet medical need. The rifamycins are one of the most potent antibiotic classes against persistent bacterial infections, but bacteria can

8-METHOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS

The invention provides compound and salts of Formula (I) and (II), disclosed herein, which includes compounds of Formula (A) and Formula (B) such compounds possess useful antimicrobial activity. The variables R2, R3, R5, R

QUINOLONE ANTIBACTERIAL AGENTS

Compounds of formula (I) wherein A is formula (II), formula (III) or formula (IV), and B is formula (V), formula (VI), or formula (VII), can be used in a variety of applications including use as antibacterial agents.